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Background: People with multi-drug resistant tuberculosis (MDR-TB) in low-income countries face many problems
during treatment, and cure rates are low. The purpose of the study was (a) to identify and document the problems
experienced by people receiving care for MDR-TB, and how they cope when support is not provided, to inform
development of strategies; (b) to estimate the effectiveness of two resultant strategies, counselling alone, and joint
counselling and financial support, of increasing DOTS-plus treatment success under routine programme conditions.
Methods: A mixed-method study comprising a formative qualitative study, pilot intervention study and explanatory
qualitative study to better understand barriers to completion of treatment for MDR-TB. Participants were all people
starting MDR-TB treatment in seven DOTS-plus centres in the Kathmandu Valley, Nepal during January to December
2008. The primary outcome measure was cure, as internationally defined.
Results: MDR-TB treatment caused extreme social, financial and employment hardship. Most patients had to move
house and leave their job, and reported major stigmatisation. They were concerned about the long-term effects of
their disease, and feared infecting others. In the resultant pilot intervention study, the two strategies appeared to
improve treatment outcomes: cure rates for those receiving counselling, combined support and no support were
85%, 76% and 67% respectively. Compared with no support, the (adjusted) risk ratios of cure for those receiving
counselling and receiving combined support were 1.2 (95% CI 1.0 to 1.6) and 1.2 (95% CI 0.9 to 1.6) respectively.
The explanatory study demonstrated that patients valued both forms of support.
Conclusions: MDR-TB patients are extremely vulnerable to stigma and extreme financial hardship. Provision of
counselling and financial support may not only reduce their vulnerability, but also increase cure rates. National
Tuberculosis Programmes should consider incorporating financial support and counselling into MDR-TB care: costs
are low, and benefits high, especially since costs to society of incomplete treatment and potential for incurable TB
are extremely high.Background
Globally, the number of people developing multi-drug
resistant TB (MDR-TB) is increasing, with an estimated
650,000 cases in 2010 [1]. In response, WHO and its
partners developed the DOTS + strategy [2], which re-
quires MDR-TB patients to take multiple powerful anti-
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reproduction in any medium, provided the orfor a minimum of 20 months. MDR-TB treatment at sites
using international standards of care was successful only
in 69% of cases [3]. A systematic review of MDR-TB treat-
ment outcomes found an overall default rate of 12% (95%
CI 0.1% to 36%) using standardized regimens [4]. Patients
who start but do not complete MDR-TB treatment are
likely to die or may develop extensively drug resistant TB
(XDR-TB), which is considered to be virtually untreatable
and a serious public health threat worldwide [5-7].
In low- and middle-income countries, daily DOT
places a major burden on patients. Furthermore, patientsd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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required to provide regular check-ups including for po-
tentially life-threatening drug side-effects. Thus patients
must move near a centralized DOTS-plus centre for at
least 20 months, meaning they are unable to continue
their employment, have to pay substantially more for ac-
commodation and food, and lose their normal family
support networks.
In our work with people with MDR-TB in Nepal [8], it
became clear that additional support was necessary [9].
The objectives of our study were therefore (a) to identify
and document the problems experienced by people
receiving care for MDR-TB, to inform development of
strategies, and (b) to estimate the effectiveness of two
resultant strategies.
The setting for our study was Nepal, a mid-TB burden
country, with a well functioning National TB Programme
(NTP). In Nepal, terrain causes problems of health service
provision [10] and TB is highly stigmatised [11]. Nepal
has been a DOTS + pilot country since November 2005,
with non-completion rates of 22%, 15% and 18% in 2005,
2006 and 2007 respectively [12].
Methods
We performed a mixed-method study including forma-
tive and explanatory qualitative components and a pilot
intervention study at the seven DOTS-plus centres that
existed in the Kathmandu Valley at the time of the study.
Prior to the start of the formative study, we randomly
allocated the DOTS-plus centres to 3 types of care – 2
to counselling, 3 to combined support, and 2 to usual
care – by selecting randomly from the numbers 1 to 7.
Individual randomization of patients was infeasible be-
cause of the certainty of contamination and consequent
disquiet among patients.
Formative study
Using purposive sampling from MDR-TB registers at the
5 intervention centres, we identified 49 registered people
with MDR-TB for interview, the sample size being based
on time and resources available: all agreed to take part.
Interviews took place in the patient’s DOTS-plus centre.
The interviews were conducted in Nepali by SCB, YA
and a public health nurse with training in patient coun-
selling: all three had experience in in-depth interviewing.
Interview guides were developed by SCB and YA based
on their experience with people with MDR-TB. Areas
explored included: socio-demographic characteristics; em-
ployment history; sources of income; living costs; reason(s)
for relocation (non-local residents only) and relocation
costs; knowledge of MDR-TB including communicability
and curability; knowledge and experience of drug side
effects and how they were addressed; care-seeking prac-
tices during diagnosis and treatment; distance to MDR-TBcentre; travel costs; interactions with family, friends and
others; and implications of daily visits to the DOTS-plus
centre. Interviews were recorded and notes taken. Inter-
views lasted between 45 and 60 minutes.
The data were coded by SCB and YA, and analysed
thematically using a framework approach, combining a-
priori and emergent themes. At the start of the coding
process, SCB and YA read the initial transcripts and
generated preliminary codes. Repeated discussion, rea-
soning and reflection during the coding process led to a
well-defined set of codes. The two researchers then coded
the remaining transcripts. When necessary, new codes
were discussed and agreed upon and the code set was up-
dated accordingly.
Pilot intervention study
We compared three groups – counselling; combined coun-
selling and financial support; and for comparison, usual
care (no support). All MDR-TB patients starting treatment
at the DOTS-plus centres from January-December 2008
were eligible for inclusion.
Patients receiving counselling were counselled indi-
vidually and in small groups by a Public Health Nurse
who was trained to provide counselling for this research.
Counselling was provided every 2–3 weeks across all
sites. The counsellor and researchers met regularly to
discuss issues raised during counselling.
Patients receiving financial support were given Nepali
Rupees (NRs) 2000 (US$ 28) per month: this was meant
to cover local transport, food and rental costs, but pa-
tients were free to use it as they chose.
Based on an assumed usual care cure rate of 70%, and
not allowing for potential effects of clustering, we esti-
mated that 62 patients were required in each group to
attain 80% power, testing at the 0.05 level (2-sided), to
detect a difference in cure rate of at least 20% between
either of the interventions and usual care. We made no
allowance for loss to follow-up, since loss to follow-up
was categorised as default. We obtained data on age and
sex for each patient from routine health service records.
In the two intervention groups, we collected additional
socio-economic data at enrolment. Patients not receiving
support were not asked for additional data, as to do so
might have started to approximate or resemble counsel-
ling, and thus reduced our ability to observe additional
effects of counselling. The epi.2by2 function of the R
[13] “epiR” package [14] was used to estimate unadjusted
and adjusted risk ratios.
Explanatory study
In the two groups that included counselling, we collected
additional qualitative information on problems that pa-
tients experienced. We used a similar approach to data
collection and the same sample (27 receiving combined
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study. Areas explored included: experience with family
members, relatives, friends, community members, and at
the workplace before and after MDR-TB; impact of illness
on general living and employment; mechanisms for coping
with MDR-TB and other associated illness; experience
with the health system especially in routine management
of illness; management of drug side effects; support from
the health system, service providers, family, relatives, at
the workplace and in the community; disclosure of their
disease status to others; problems/issues experienced by
the respondents and their management; and perceptions
of the interventions. Data was analysed using the proce-
dures described above for the formative study.
Ethics approval was granted by the Nepal Health Re-
search Council.
Results
All eligible patients agreed to take part in each of the
three parts of the study, and all participants gave verbal
informed consent.
Results from the formative study
The formative study aimed to explore patients’ explana-
tions of the impact of MDR-TB and its treatment. These
impacts can be categorised into three broad categories.
Social and psychological impacts
Respondents experienced substantial enacted stigma, lead-
ing to divorce, cancellation of impending marriages, break-
down of family relationships, and isolation within the
family. Most reported that neighbours harassed them both
directly and through unpleasant gossip and many experi-
enced hatred or avoidance by friends and neighbours.
Landlords evicted patients from, or rejected applications
for, rented accommodation. Many experienced discrimin-
ation in public places. Health workers were often accused
of discrimination.
“Hotels and cafes won’t let me use their plates: I have
to take my own.”“I was evicted from my rented room. The house owner
blamed me for the death of her son: she thought I
transmitted my disease to him.”
This discrimination was seen partly because of fear of be-
ing infected, although respondents thought TB was some-
times used as a concrete excuse to discriminate against
more intangible attributes such as dislike. However, many
respondents reported that once their sputum tests became
negative, and they looked healthy again, they got better re-
sponses from family, friends and neighbours.Many respondents also reported perceived stigma. Some
hid their disease and isolated themselves for complex rea-
sons combining fear of discrimination and fear of infecting
others. A few believed it was good to relocate for treat-
ment to a place where they were not known, because of
the reduced risk of disease disclosure, but found managing
costs of relocation very difficult.
Respondents felt guilt leaving their families while
they received treatment, not only because they were
unable to maintain their contribution, but because they
became major burdens. Some regarded MDR-TB as
divine punishment for misdeeds, exacerbating feelings
of guilt.
“I feel guilty because I got married a few months before
getting diagnosed with MDR-TB. I ruined her life.”
Because they had to relocate to receive treatment,
many respondents lost the support of their family and
community. Isolation led to misery, boredom and intro-
spection. Some felt suicidal because of the burden they
placed on the family.
“There’s no-one here to help. I wish I could be with my
family during this difficult time.”“If the tests come back positive this time, I’ll kill myself –
there’s no point being alive like this.”
Most respondents recommended expanding services
so that patients could take treatment at home. They
believed that this would speed recovery. Some patients
expressed a desire or compulsion to return to their homes
even though this meant missing treatment.
“Once I visited home and felt very happy and relaxed
to be with my grandchildren. I feel that it would be
good to be able to take [DOTS-plus] treatment at
home.”Employment, educational and financial impacts
Most respondents had to leave their job and did not find
re-employment, causing major hardship. This occurred
primarily because they had to relocate to access the
DOTS-plus Centre, and found it difficult to get re-
employment because they had to visit the DOTS-plus
Centre daily. The very few who continued working re-
ported that their illness lowered their performance, lead-
ing to employers’ dissatisfaction and consequent feelings
of humiliation. Students were not able to perform as be-
fore due to impaired intellect and memory, leading to feel-
ings of guilt. Younger people were very worried, as they
perceived their counterparts’ careers progressed while
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rent and daily travel to the DOTS-plus Centre; and sub-
stantially higher food and other costs than usual.
“I’m in a big financial mess: I had to leave my job and
my debts are increasing day by day.”
Often, patients coped by getting financial support from
their family, borrowing money from friends or relatives,
or taking a loan. They also sold long-term means of sur-
vival such as land, animals and equipment (one respond-
ent sold his vegetable-selling cart) and other assets such
as jewellery dowries. Often children were taken out of
school and sent to work, to save school fees and gener-
ate income.
“I took a loan to come to the city. I don’t know when
I“ll be able to repay it as I have no income.”“I only eat twice a day, have sold my animals and
land, and taken out a loan.”
Health impacts
Patients had major worries relating to their health. They
were unclear about the curability of their disease, and
feared relapse after treatment completion. They worried
about the effects of MDR-TB drugs and the disease it-
self. They were concerned about transmitting the dis-
ease: many had experience of several people with TB in
one family.
“I doubt the curability of my disease. I was told my TB
would be cured if I took the medicine regularly, but I
took it regularly, and even now I’m taking it regularly,
but I’m still not cured [and my TB has returned]. I
think I’ll die due to the disease” (relapsed MDR-TB
patient).“I feel like a victim.”
Their frustration was increased because they had mul-
tiple problems.
“I am upset having to take so much medicine, not
having a job, feeling bored because of having no work,
and being a long time away from home, as well as
spending without any income and with no other
earner in the family.”
A substantial majority of respondents encountered
side-effects of MDR-TB drugs. Most consulted the
DOTS-plus Centre, but the side-effects continued to dis-
rupt daily DOT and hinder their daily activities. Two re-
ported mental effects so severe that they were arrestedand jailed. Some wanted to stop treatment because of
the side effects.
“I was jailed, and still have scars from the beating the
police gave me. Initially I had great difficulty in taking
the medicine.”“It’s the medicine rather than the disease itself that
makes life so difficult.”
Our conclusion from this formative study was that
MDR-TB patients would probably benefit from counsel-
ling and/or financial support, and thus developed a pilot
intervention study with three arms – counselling; com-
bined counselling and financial support; and for com-
parison, usual care (no support).
Results from the pilot intervention study
Combined counselling and financial support was provided
by 3 DOTS-plus centres: a government clinic (National
TB Centre) which acts as a national referral centre for
MDR-TB; a semi-governmental hospital (Patan Hospital)
with dedicated personnel for lab and clinic management;
and a non-governmental organisation (Helping Hands)
providing basic MDR-TB treatment services. Counselling
was provided by two clinics: a community based hospital
(Stupa Hospital) that mainly caters for migrants; and a
government clinic located within a central level hospital
(Bir Hospital) with a wide range of health services. Clinics
providing usual care (no support) were: a teaching hospital
(Nepal Medical College) with an in-patient facility and
other specialised care; and an NGO run clinic (NATA/
GENETUP) with advanced TB diagnosis and treatment
facilities.
Lower than expected enrolment in our study DOTS-
plus centres due to (limited) expansion of centres in
Nepal meant we enrolled only 33 patients to receive
counselling and 42 to receive combined support. As par-
tial compensation, we increased numbers on the no-
support group to 81, to reduce the expected width of
confidence intervals of comparisons. All eligible individ-
uals consented to participate in the study.
Distributions of sex and age were similar across all
three groups (Table 1); and in addition distributions of
marital status, occupation, origin and residence (for mi-
grants only) were similar across the two intervention
groups (Table 2). Most were from the economically pro-
ductive age group, but were not working at the time of
interview. Most had moved for treatment and were stay-
ing in a rented room. Farming was the most common
source of income. Median incomes and outgoings of the
counselling and combined support groups were similar:
annual family cash income was NRs 72,000 (US$ 1,028);
annual rent paid by participants staying in rented
Table 1 General characteristics of study participants
Type of support provided
Counselling Combined None
N (%) N (%) N (%)
Sex
Male 20 (61) 30 (71) 51 (63)
Female 13 (39) 12 (29) 30 (37)
Total 33 (100) 42 (100) 81 (100)
Age group
≤20 3 (9) 6 (14) 12 (15)
21-30 19 (58) 13 (31) 33 (41)
31-40 3 (9) 7 (17) 16 (20)
41-50 6 (18) 8 (19) 14 (17)
51-60 2 (6) 5 (12) 3 (4)
>60 0 (0) 3 (7) 3 (4)
Total 33 (100) 42 (100) 81 (100)
Table 2 Additional characteristics of patients receiving
support
Type of support provided
Counselling Combined
N (%) N (%)
Marital Status
Unmarried 19 (58) 18 (43)
Married 14 (42) 23 (55)
Other (d/w/s) 0 (0) 1 (2)
Total 33 (100) 42 (100)
Occupation
Unemployed 18 (55) 38 (91)
Labourer 2 (6) 1 (2)
Housewife 3 (9) 0 (0)
Business 2 (6) 0 (0)
Student 4 (12) 3 (7)
Agriculture 2 (6) 0 (0)
Service 1 (3) 0 (0)
Other 1 (3) 0
Total 33 (100) 42 (100)
Origin
Local 10 (30) 7 (17)
Migrant 23 (70) 35 (83)
Total 33 (100) (100) 42
Residence (among migrants only)
Rented room 17 (74) 25 (71)
Friend’s home 1 (4) 2 (6)
Relative’s home 4 (18) 7 (20)
Other 1 (4) 1 (3)
Total 23 (100) 35 (100)
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costs were NR 68,000 (US$ 971); and average cost of
travel for DOT was NRs 7,000 (US$ 100).
Table 3 gives treatment outcomes by support group.
Cure rates for those receiving counselling, combined
support and no support were 85%, 76% and 67% respect-
ively. Compared with no support, the unadjusted risk ra-
tios of cure for those receiving counselling and
combined support were 1.3 (95% CI 1.0-1.6) and 1.2
(95% CI 0.9-1.5) respectively. Risk ratios were virtually
unchanged when adjusted for sex or age group using the
Mantel-Haenszel method.
Since it was possible that support influenced default but
not death or failure, we reanalysed the data excluding pa-
tients whose outcome was death or failure. Cure rates
were 93%, 84% and 78% respectively. Unadjusted risk ra-
tios of cure for those receiving counselling and combined
support were 3.9 (95% CI 0.8-18.2) and 1.4 (95% CI 1.1-
1.7) and 1.1 (95% CI 0.8-1.6) respectively. Again, risk ra-
tios were largely unchanged when adjusted for age group
using the Mantel-Haenszel method.
Results from the explanatory study
Social and psychological impacts
Those receiving counselling took some time to become
comfortable with the counsellor and talk openly. Many
wept and became very emotional while sharing their
problems. They reported that they liked having someone
to listen to their problems and give support without dis-
crimination. Their fear was reduced by discussing infor-
mation about the disease and its treatment. Negative
thoughts reduced and self-esteem increased. The coun-
sellors were described as being like good friends indifficult times, especially by those staying alone in rented
accommodation.
“… a big relief to talk to you …”“… it would be good if it [counselling] continues as
otherwise there is no one who listens to us.”
Those receiving combined support found it very
helpful and believed all patients should receive it. Ini-
tially some patients did not like visiting the DOTS-
plus Centre but this attitude changed as they shared
problems with counsellors. They reported that the sup-
port increased their self-esteem and their belief that
they would be cured, and decreased their worries.
Many patients stated that the support had given them
a new life. Those receiving combined support seemed
Table 3 Treatment outcomes
Outcome Type of support
Counselling Combined None
N (%) N (%) N (%)
Cured 28 (85) 32 (76) 54 (67)
Defaulted 2 (6) 6 (14) 15 (19)
Died 1 (3) 2 (5) 8 (10)
Failed 2 (6) 2 (5) 4 (5)
Total 33 (100) 42 (100) 81 (100)
Unadjusted and adjusted* risk ratios (RR)
Type of support
Counselling Combined
RR (95% CI) RR (95% CI)
(a) for cure versus other outcomes, taking the No Support group as
baseline
RR 1.3(1.0, 1.6) 1.2 (0.9, 1.5)
RR adjusted for sex 1.3 (1.0, 1.6) 1.2 (0.9, 1.5)
RR adjusted for age group 1.2 (1.0, 1.6) 1.2 (0.9, 1.6)
(b) for cure versus default, taking the No Support group as baseline
RR 1.4 (1.1, 1.7) 1.1 (0.8, 1.6)
RR adjusted for sex 1.3 (1.1, 1.7) 1.1 (0.8, 1.5)
RR adjusted for age group 1.2 (1.0, 1.6) 1.2 (0.9, 1.6)
*Adjusted using the Mantel-Haenszel method.
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ing counselling: this seemed to be because counselling
worked better when they were not overwhelmed by fi-
nancial problems.
“… God sent you to provide this support.”
Employment, educational, and financial impacts
Although those receiving counselling said their stress
was relieved by sharing their problems, they continued
to have financial problems that counselling could not
fully address. Even through they explicitly said they
were happy with the support provided, many missed or
were late for counselling because of financial and other
problems.
Most of those receiving combined support used the
money for food (including food additional to normal
consumption), rent and travel costs. Some said they
were entirely dependent on the support: many believed
they would otherwise have died as there was nothing
available for them to eat. Some remitted money to solve
financial problems at home. However, some were not
able to use the support money as their family took it.
Some commented that although the amount given was
helpful, more would have been more useful. Unsurpris-
ingly, the financial component was most appreciated bypatients who were very poor and had also had to
relocate.
“I would have died if I did not get support from you.”“I get financial support for additional food – but how
can I eat it when my children are hungry?”“I used to eat only once a day. Now I can buy food
and pay rent.”
However, a few richer patients did not value the sup-
port, seeing it as pocket money. Consequently, such pa-
tients did not come on time and did not take counselling
seriously.
Health impacts
Participants from both groups reported improved under-
standing of the likelihood of cure, and solved many prob-
lems related to their disease and its treatment. These
included duration of treatment, management of drugs and
understanding of side-effects.
Discussion
We found that our respondents reported that DOTS-plus
treatment caused serious financial and social problems.
Financial problems were caused by greatly increased ex-
penses due to having to move near to the DOTS-plus
Centre. Social problems included a lack of social support
following patients’ removal from their normal social net-
work, stigma, loneliness, and toxic effects of drugs. Since
our study started there has been some limited expansion
in DOTS-plus provision, including some hostel spaces,
which reduces accommodation costs, and minimum treat-
ment duration is now 20 months, but the great majority
of patients still need to relocate for nearly two years.
We found that both counselling alone and combined
counselling and financial support were valued by patients.
In general, we found that those getting combined support
were more appreciative of counselling than those receiv-
ing counselling alone.
Both forms of support appeared to have a beneficial ef-
fect on treatment outcomes, although differences were
not significant. This finding is not unexpected, given the
problems MDR-TB patients face.
We were unable to find any published studies giving
evidence either on the problems people with MDR-TB
face during treatment, nor on the effectiveness of inter-
ventions to address these problems.
The study has several limitations. The sample sizes of
the pilot intervention were less than planned, and did
not take clustering (by DOTS-plus centre) into account,
so we may not have had the power to detect true effects.
Although the three groups were comparable in sex and
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comparable on the other factors recorded, the groups
may or may not have been comparable on unrecorded
factors: it is difficult to assess the effects of differences in
the DOTS-plus centres involved. Analysis did not take
clustering into account, due to the limited numbers
of clusters. Caution should be taken when generalis-
ing the results: in general it can be difficult to gener-
alise qualitative results; and the study was restricted
to the Kathmandu Valley.
The study has a number of strengths. The formative
studies allowed the key people involved – those receiv-
ing treatment for MDR-TB – to express the problems
they face in continuing treatment, untainted by the re-
searchers’ preconceptions, and guided development of
the intervention. The mixed method approach allowed a
clearer interpretation of the formative and pilot inter-
vention studies. Findings accord with anecdotal experi-
ences across many countries.
Conclusions
We have demonstrated that DOTS-plus treatment causes
serious financial and social problems, that both counsel-
ling alone and combined counselling and financial support
were valued by patients, and that financial and counselling
support appear to improve MDR-TB treatment outcomes.
Larger studies, and preferably randomised controlled trials
(RCTs), are required to confirm our preliminary findings
on the effectiveness of these strategies and estimate their
cost-effectiveness. However, even before RCTs (which will
take at least 4 years) are completed, NTPs should consider
how they can support this disadvantaged and vulnerable
group of people. Based on this study, the Nepal NTP now
gives each MDR-TB patient NRs 1500 (US$ 21) per month
during treatment. NTPs should consider doing their own
operational research to determine the type(s) of support
most appropriate and effective in their context.
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